Stifel raises Zimmer Biomet stock target to $138 on strong outlook
Stifel analysts increased their price target for Zimmer Biomet Holdings Inc (NYSE:ZBH) shares from $130.00 to $138.00, while reiterating a Buy rating on the stock. The firm expressed confidence in the ...
manilatimes3h
Stifel Financial Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call
Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market ...
Stifel lifts MasTec stock price target to $185 on growth outlook
Stifel analysts increased the price target for MasTec (NYSE:MTZ) shares to $185 from the previous target of $155, while ...
Cytokinetics started at buy by Stifel, aficamten highlighted
Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...